seed
Stage
About
Cellens Inc develops a noninvasive, urine-based cancer diagnostics platform using nanoscale biophysical markers and machine learning to accurately detect bladder cancer and potentially other cancer types from bodily fluids.
Explore Cellens Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.